Circulating endothelial progenitors in vascular repair
Source abstract
Abstract
Endothelial Colony Forming Cells (ECFCs) are obtained in culture from Circulating Endothelial Progenitor Cells. They display all characteristics of endothelial cells and they display stem cells features. Cord blood-derived ECFCs (CB-ECFCs) have a high clonogenic and proliferative potentials, and exhibit vascular repair capabilities useful for the treatment of ischemic diseases. However, the link between immaturity and functional properties of CB-ECFCs is still poorly defined. We showed that these cells have a high clonogenic potential and are capable to be efficiently reprogrammed into induced pluripotent stem cells. Moreover, we analyzed the expression of a broad panel of genes involved in embryonic stem cell properties. We define a novel stem cell transcriptional signature for CB-ECFCs fora better characterization and stratification according to their stem cell profile. We then improved the yield of CB-ECFC production for obtaining cells more functional in fewer passages. We used Glycosaminoglycans (GAG), components from the extracellular matrix which potentiate heparin binding growth factor activities. GAG mimetics were designed, having the capacity to increase the yield of ECFC during the isolation process, to increase the number of colonies, improve adhesion, proliferation, migration and self-renewal. GAG mimetics have thus great interest for vascular regeneration in combination with ECFC. Our results show that CB-ECFC are immature cells harboring specific functions such as formation of colonies, proliferation and formation of vascular structures in vitro and in vivo.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Angiogenesis and VEGF in Cancer · Congenital heart defects research · Pluripotent Stem Cells Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Inserm U1197, Hôpital Paul Brousse, Bâtiment Lavoisier, 12-14 avenue Paul Vaillant Couturier, 94807 Villejuif Cedex, France
References (55)
Show source-provided references
1. Isolation of putative progenitor endothelial cells for angiogenesis10.1126/science.275.5302.964 ↗
2. Post-natal endothelial progenitor cells for neovascularization in tissue regeneration10.1016/S0008-6363(02)00785-X ↗
3. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization10.1038/7434 ↗
4. Statin therapy accelerates reendothelialization: A novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells10.1161/01.CIR.0000018166.84319.55 ↗
5. Estrogen-mediated endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury10.1161/01.CIR.0000106906.56972.83 ↗
6. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals10.1182/blood-2006-08-043471 ↗
7. Working hypothesis to redefine endothelial progenitor cells10.1038/sj.leu.2404676 ↗
8. 10.1186/scrt11410.1186/scrt114 ↗
9. Human endothelial cells derived from circulating progenitors display specific functional properties compared with mature vessel wall endothelial cells10.1182/blood-2003-08-2770 ↗
10. Differential in vivo potential of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood to form functional long-lasting vessels10.1182/blood-2007-06-094318 ↗
11. Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: Insights from a novel human angiogenesis assay10.1016/j.jacc.2007.09.059 ↗
12. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood10.1182/blood-2004-04-1396 ↗
13. J. Boyer-Di Ponio, F. El-Ayoubi, F.G. Glacial, K. Ganeshamoorthy, C. Driancourt, M. Godet, N. Perrière, O. Guillevic, P.O. Couraud and G. Uzan, Instruction of circulating endothelial progenitors in vitro towards specialized blood-brain barrier and arterial phenotypes, PLoS One, 9 (2014), e84179.10.1371/journal.pone.0084179 ↗
14. In vitro differentiation of endothelial cells from AC133-positive progenitor cells10.1182/blood.V95.10.3106 ↗
15. Oct-4: Control of totipotency and germline determination10.1002/(SICI)1098-2795(200004)55:4<452::AID-MRD14>3.0.CO;2-S ↗
16. Endothelial outgrowth cells are not derived from CD 133 + cells or CD 45 + hematopoietic precursors10.1161/ATVBAHA.107.144972 ↗
17. Human CD 34 +AC 133 +VEGFR − 2 + cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors
18. Oct-4 expression in adult human differentiated cells challenges its role as a pure stem cell marker10.1634/stemcells.2006-0611 ↗
19. Induction of pluripotent stem cells from mouse fibroblast cultures
20. The structure of glycosaminoglycans and their interactions with proteins chem10.1111/j.1747-0285.2008.00741.x ↗
21. Multiprotein signalling complexes: Regional assembly on heparansulphateBiochem
22. Nondegradativesulfation of polysaccharides. Synthesis and structure characterization of biologically active heparan sulfate mimetics10.1021/ma048485p ↗
23. Pharmacological studies of RGTA 11, a heparan sulfate mimetic polymer, efficient on muscle regeneration10.1002/jbm.10283 ↗
24. A synthetic glycosaminoglycan mimetic binds vascular endothelial growth factor and modulates angiogenesis10.1074/jbc.M504492200 ↗
25. Glycosaminoglycan mimetics-induced mobilization of hematopoietic progenitors and stem cells into mouse peripheral blood: Structure/function insights10.1016/j.exphem.2009.06.005 ↗
26. Glycosaminoglycan mimetic associated to human mesenchymal stem cell-based scaffolds inhibit ectopic bone formation, but induce angiogenesis in vivo10.1089/ten.tea.2012.0377 ↗
27. AC133, a novel marker for human hematopoietic stem and progenitor cells10.1182/blood.V90.12.5002 ↗
28. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells10.4049/jimmunol.133.1.157 ↗
29. Antigen CD 34 + marrow cells engraft lethally irradiated baboons10.1172/JCI113409 ↗
30. Expression of the CD34 gene in vascular endothelial cells10.1182/blood.V75.12.2417.2417 ↗
31. Identification of podocalyxin-like protein 1 as a novel cell surface marker for hemangioblasts in the murine aorta-gonad-mesonephros region10.1016/S1074-7613(00)80132-6 ↗
32. Evaluating the expression of self-renewal genes in human endothelial progenitor cells
33. Molecular cloning and characterization of human podocalyxin-like protein. Orthologous relationship to rabbit PCLP1 and rat podocalyxin10.1074/jbc.272.25.15708 ↗
34. Identification of podocalyxin-like protein as a high endothelial venule ligand for L-selectin: Parallels to CD3410.1084/jem.187.12.1965 ↗
35. GDF3, a BMP inhibitor, regulates cell fate in stem cells and early embryos10.1242/dev.02192 ↗
36. The Vg1-related protein Gdf3 acts in a nodal signaling pathway in the pre-gastrulation mouse embryo10.1242/dev.02210 ↗
37. Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart10.1016/S1534-5807(03)00363-0 ↗
38. Multipotent embryonic isl 1 + progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification10.1016/j.cell.2006.10.029 ↗
39. Embryonic stem cell lines derived from human blastocysts10.1126/science.282.5391.1145 ↗
40. Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases10.1038/890 ↗
41. Ex-vivo expanded umbilical cord blood stem cells retain capacity for myocardial regeneration10.1253/circj.CJ-09-0409 ↗
42. B. Janic, A.M. Guo, A.S. Iskander, N.R. Varma, A.G. Scicli and A.S. Arbab, Human cord blood-derived AC 133 + progenitor cells preserve endothelial progenitor characteristics after long term in vitro expansion. PLoS One 5 (2010), e9173.10.1371/journal.pone.0009173 ↗
43. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization10.1073/pnas.97.7.3422 ↗
44. In vitro and in vivo analysis of endothelial progenitor cells from cryopreserved umbilical cord blood: Are we ready for clinical application?10.3727/096368910X504487 ↗
45. Epigenetic events in mammalian germ-cell development: reprogramming and beyond10.1038/nrg2295 ↗
46. Chondroitin sulfate “wobble motifs” modulate maintenance and differentiation of neural stem cells and their progeny10.1074/jbc.R111.298430 ↗
47. Heparan sulfate: A key regulator of embryonic stem cell fate10.1515/hsz-2012-0353 ↗
48. Heparin regulates vascular endothelial growth factor165-dependent mitogenic activity, tube formation, and its receptor phosphorylation of human endothelial cells. Comparison of the effects of heparin and modified heparins10.1074/jbc.M414581200 ↗
49. The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules10.1016/S0021-9258(18)42666-X ↗
50. Binding affinities of vascular endothelial growth factor (VEGF) for heparin-derived oligosaccharides10.1042/BSR20110077 ↗
51. lycosaminoglycans mimetics potentiate the clonogenicity, proliferation, migration and differentiation properties of rat mesenchymal stem cells10.1016/j.scr.2011.09.005 ↗
52. CCR2 chemokines bind selectively to acetylated heparan sulfate octasaccharides10.1074/jbc.M703387200 ↗
53. Importance of CXC chemokine receptor 2 in the homing of human peripheral blood endothelial progenitor cells to sites of arterial injury10.1161/01.RES.0000259043.42571.68 ↗
54. New agents for the treatment of infarcted myocardium10.1096/fj.99-0565fje ↗
55. Mechanical signaling and the cellular response to extracellular matrix in angiogenesis and cardiovascular physiology10.1161/01.RES.0000039537.73816.E5 ↗